Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients (Alliance)
- Citation:
- European Journal of Cancer vol 138 (Supplement 2) S9-S10
- Meeting Instance:
- ENA / AACR - MTCT 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3232
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, UG1CA233253, UG1CA233327, UG1CA233373, São Paulo Research Foundation-FAPESP (2018/04491-2)
- Corr. Author:
- Authors:
- Federico Innocenti Jin Wang Alexander B. Sibley Chen Jiang Amy S. Etheridge Fei Shen Jai N. Patel Daniel L. Hertz Elizabeth Claire Dees Howard L. McLeod Monica Bertagnolli Hope Rugo Hedy L. Kindler William Kevin Kelly Mark J. Ratain Deanna L. Kroetz Kouros Owzar Bryan Schneider Danyu Lin Júlia C.F. Quintanilha.
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-40502, CALGB-40503, CALGB-80303, CALGB-90401
- Phases:
- 3
- Keywords:
- Bevacizumab, hypertension, proteinuria.